<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="773">
  <stage>Registered</stage>
  <submitdate>20/09/2005</submitdate>
  <approvaldate>9/11/2005</approvaldate>
  <actrnumber>ACTRN12605000723684</actrnumber>
  <trial_identification>
    <studytitle>Psychotherapy for depression: a comparison of two cognitive treatments</studytitle>
    <scientifictitle>A randomised trial of cognitive behaviour therapy and schema focused therapy in major depression to reduce depressive symptoms over six months.</scientifictitle>
    <utrn />
    <trialacronym>CCT</trialacronym>
    <secondaryid>Nil known</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Depression</healthcondition>
    <conditioncode>
      <conditioncode1>Mental Health</conditioncode1>
      <conditioncode2>Depression</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Cognitive Behaviour Therapy (CBT) versus Schema Focused Therapy (SFT).
Duration: 12 months.</interventions>
    <comparator />
    <control>Active</control>
    <interventioncode>Treatment: Other</interventioncode>
    <interventioncode>Behaviour</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>To test the hypothesis that SFT is superior to CBT in achieving sustained change in depression as judged by independent clinician ratings (MADRS)</outcome>
      <timepoint>Over the last 6 months of treatment.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>i) To compare SFT with CBT on i) Outcomes</outcome>
      <timepoint>At the end of the weekly sessions.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>ii) Sustained change on a self-report measure (BDI-II) of depressive symptoms</outcome>
      <timepoint />
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>iii) Remission (MADRS &amp; BDI-II&lt;10 for 2 weeks) and recovery (MADRS &amp; BDI-II&lt;10 for 8 weeks).</outcome>
      <timepoint>At the end of weekly sessions and during the following monthly sessions.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Individuals currently experiencing a major depressive episode (DSM-IV). All people accepted into the study need to be free of any centrally acting drugs (except an occasional hypnotic or the oral contraceptive) and who are able to be safely managed with outpatient psychotherapy.</inclusivecriteria>
    <inclusiveminage>16</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>Not stated</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>No exclusion criteria</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Sealed envelopes.</concealment>
    <sequence>Computer generated permutated block randomisation</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>20/10/2003</anticipatedstartdate>
    <actualstartdate>6/11/2003</actualstartdate>
    <anticipatedenddate />
    <actualenddate>10/09/2008</actualenddate>
    <samplesize>150</samplesize>
    <actualsamplesize>100</actualsamplesize>
    <recruitmentstatus>Completed</recruitmentstatus>
    <anticipatedlastvisitdate />
    <actuallastvisitdate>4/11/2013</actuallastvisitdate>
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>,Outside</recruitmentcountry>
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state>Christchurch, Canterbury, New Zealand</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Government body</primarysponsortype>
    <primarysponsorname>Lottery Grants Board</primarysponsorname>
    <primarysponsoraddress>Lottery Health Research Committee
c/- Local Government and Community Branch
Department of Internal Affairs
PO Box 805
WELLINGTON 6140</primarysponsoraddress>
    <primarysponsorcountry>New Zealand</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Government body</fundingtype>
      <fundingname>Lottery Grants Board</fundingname>
      <fundingaddress>Lottery Health Research Committee
c/- Local Government and Community Branch
Department of Internal Affairs
PO Box 805
WELLINGTON 6140</fundingaddress>
      <fundingcountry>New Zealand</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname>Not applicable</sponsorname>
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary />
    <trialwebsite />
    <publication>Carter JD, McIntosh VV, Jordan J, Porter RJ, Frampton CM, Joyce PR. Psychotherapy for depression: A randomized clinical trial comparing schema therapy and cognitive behavior therapy. J Affect Disord. 2013;151(2):5005.

Porter R, Bourke C, Carter J, Douglas K, McIntosh V, Jordan J, et al. No change in neuropsychological dysfunction or emotional processing during treatment of major depression with cognitivebehaviour therapy or schema therapy. Psychol Med. 2015:1-12.

Jordan J, Wilson J, Carter J, McIntosh V. Cognitive therapy and schema therapy in depression. New Zealand Clinical Psychologist Journal. 2006;16(2):19-23.
</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Canterbury Ethics Committee</ethicname>
      <ethicaddress />
      <ethicapprovaldate>19/06/2003</ethicapprovaldate>
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>New Zealand</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Professor Peter Joyce</name>
      <address>Department of Psychological Medicine
Christchurch School of Medicine and Health Sciences
PO Box 4345
Christchurch 8001</address>
      <phone>+64 3 3720400</phone>
      <fax>+64 3 3720407</fax>
      <email>peter.joyce@chmeds.ac.nz</email>
      <country>New Zealand</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Professor Peter Joyce</name>
      <address>Department of Psychological Medicine
Christchurch School of Medicine and Health Sciences
PO Box 4345
Christchurch 8001</address>
      <phone>+64 3 3720400</phone>
      <fax>+64 3 3720407</fax>
      <email>peter.joyce@chmeds.ac.nz</email>
      <country>New Zealand</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>